Immunohematology Market Opportunities, Trends, and Forecasts to 2027
On this note, the global Immunohematology Market size is estimated to surpass USD 3 billion by 2027, as per the latest study by Global Market Insights Inc.
Rising cases of blood disorders across the globe and the need for accurate blood tests will complement the immunohematology market size. Blood disorders such as hemophilia have become more common in recent years. Reports have it that type-A hemophilia is four times more prevalent and predominant as compared to any other type of hemophilia.
New advancements made in the discovery of therapeutic agents, growing awareness regarding hemophilia, and efforts taken by governments for screening of such diseases will endorse the immunohematology industry expansion.
As per reports by Global Market Insights, Inc., the immunohematology market size is expected to amass USD 3 billion in value through 2027. Factors that will incite this growth include:
To access a sample copy or view the market report in detail along with the table of contents, please click the link below: https://www.gminsights.com/request-sample/detail/1652
Adoption of biochips/biosensors
Biochips are used to determine blood group genotyping. As per the International Society of Blood Transfusion, nearly 33 different types of blood groups are recorded and it comprises of 300 different antigens. Biochips and microplates are used to determine complex blood groups and different diseases.
The advent of coronavirus has supported the adoption of biochips across the healthcare industry. For example, in July 2021, Russia announced the use of a non-implantable biochip being developed by the Blokhina Institute of Epidemiology and Microbiology to detect infectious agents that cause acquired pneumonia including coronavirus.
Rise in cases of anemia in APAC
Asia Pacific has emerged as a key revenue pocket for immunohematology market as the region observes a spike in number of cases of anemia in pregnant women and children. A World Health Organization report states that one-third of the world population is anemic, with Southeast Asia and Africa accounting for 85% of the burden.
Rising cases of anemia in pregnant women are relatively higher in APAC leading to cases of stillbirth, malnutrition, miscarriages, and others. Increasing prevalence of lifestyle disorders, surging cases of malnutrition, and increasing prevalence of iron-deficient anemia will offer impetus to immunohematology companies.
Demand for immunohematology reagents
The immunohematology reagents segment was responsible for 66% of the total market share in the year 2020 and is likely to register considerable growth in the times to come. The demand for accurate blood tests have risen to a great extent, especially since a noticeable increase in the prevalence of chronic diseases. The need to ensure early-diagnosis of some of the most lethal diseases makes blood tests of key significance.
Reagents are the chemicals or biological products that are used to carry out blood tests. Increasing health awareness among people and increasing frequency of health check-ups will drive the demand for immunohematology reagents.
Heightening requirement for blood banks
There is a pressing need for new blood banks across emerging countries, with efforts taken by the governments to fund blood centers and campaigns. Increasing cases of road accidents have driven the need for blood to conduct complex surgeries.
According to a report by UK’s Department for Transport, there were nearly 131,220 severe road casualties reported in the UK as of June 2020. Many government organizations and NGOs are actively working to raise awareness regarding blood donations that are further used in blood banks to support patients need.
New business expansion efforts
Companies specializing in immunohematology landscape are extending their market presence by way of mergers and acquisitions and by forming strategic partnerships. They are heavily investing in R&D to develop advanced products that meet the needs of hospitals, laboratories, clinics, and other medical centers.
In March 2021, Switzerland-based- Roche Diagnostics inked a definitive merger agreement with GenMark to expand its molecular diagnostics portfolio to include solutions that can offer lifesaving data to patients and their healthcare providers to ensure early diagnosis and treatment of infectious diseases.
Other notable immunohematology companies include:
- Siemens Healthcare GmbH
- Ortho Clinical Diagnostics
- Abbott, Hologic
- Bio-Rad Laboratories
Partial Table of Contents (ToC) of the report:
Chapter 4 Immunohematology Market, By Product
4.1 Key segment trends
4.2.1 Market size, by region, 2016 – 2027 (USD Million)
4.3.1 Market size, by region, 2016 – 2027 (USD Million)
Chapter 5 Immunohematology Market, By Technology
5.1 Key segment trends
5.2.1 Market size, by region, 2016 – 2027 (USD Million)
5.3 Gel Cards
5.3.1 Market size, by region, 2016 – 2027 (USD Million)
5.4.1 Market size, by region, 2016 – 2027 (USD Million)
5.5.1 Market size, by region, 2016 – 2027 (USD Million)
5.6 Erythrocyte-Magnetized Technology
5.6.1 Market size, by region, 2016 – 2027 (USD Million)
5.7.1 Market size, by region, 2016 – 2027 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/immunohematology-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: +1-888-689-0688